Stebėti
Utaroh Motosugi
Utaroh Motosugi
Department of Radiology, University of Yamanashi
Patvirtintas el. paštas nifty.com
Pavadinimas
Cituota
Cituota
Metai
Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data
S Singh, SK Venkatesh, Z Wang, FH Miller, U Motosugi, RN Low, ...
Clinical Gastroenterology and Hepatology 13 (3), 440-451. e6, 2015
6282015
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid–enhanced MR imaging
K Sano, T Ichikawa, U Motosugi, H Sou, AM Muhi, M Matsuda, M Nakano, ...
Radiology 261 (3), 834-844, 2011
3892011
Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid–enhanced MR imaging in differential diagnosis
L Grazioli, MP Bondioni, H Haradome, U Motosugi, R Tinti, B Frittoli, ...
Radiology 262 (2), 520-529, 2012
3402012
High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results
T Ichikawa, SM Erturk, U Motosugi, H Sou, H Iino, T Araki, H Fujii
American Journal of Roentgenology 188 (2), 409-414, 2007
3302007
High-B-value diffusion-weighted MRI in colorectal cancer
T Ichikawa, SM Erturk, U Motosugi, H Sou, H Iino, T Araki, H Fujii
American Journal of Roentgenology 187 (1), 181-184, 2006
3192006
Liver parenchymal enhancement of hepatocyte‐phase images in Gd‐EOB‐DTPA‐enhanced MR imaging: which biological markers of the liver function affect the enhancement?
U Motosugi, T Ichikawa, H Sou, K Sano, L Tominaga, T Kitamura, T Araki
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
3072009
Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid–enhanced MR imaging
U Motosugi, T Ichikawa, H Sou, K Sano, L Tominaga, A Muhi, T Araki
Radiology 256 (1), 151-158, 2010
2262010
Detection of pancreatic carcinoma and liver metastases with Gadoxetic acid–enhanced MR imaging: comparison with contrast-enhanced multi–detector row CT
U Motosugi, T Ichikawa, H Morisaka, H Sou, A Muhi, K Kimura, K Sano, ...
Radiology 260 (2), 446-453, 2011
2232011
High‐b‐value diffusion‐weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma
A Muhi, T Ichikawa, U Motosugi, K Sano, M Matsuda, T Kitamura, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
2152009
Diagnosis of colorectal hepatic metastases: comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRI
A Muhi, T Ichikawa, U Motosugi, H Sou, H Nakajima, K Sano, M Sano, ...
Journal of Magnetic Resonance Imaging 34 (2), 326-335, 2011
2002011
Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers
P Bannas, H Kramer, D Hernando, R Agni, AM Cunningham, R Mandal, ...
Hepatology 62 (5), 1444-1455, 2015
1882015
Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C
S Ichikawa, U Motosugi, T Ichikawa, K Sano, H Morisaka, N Enomoto, ...
Magnetic Resonance in Medical Sciences 11 (4), 291-297, 2012
1512012
Diagnosis of Peritoneal Dissemination: Comparison of 18F-FDG PET/CT, Diffusion-Weighted MRI, and Contrast-Enhanced MDCT
Y Satoh, T Ichikawa, U Motosugi, K Kimura, H Sou, K Sano, T Araki
American Journal of Roentgenology 196 (2), 447-453, 2011
1442011
Motion artifact reduction using a convolutional neural network for dynamic contrast enhanced MR imaging of the liver
D Tamada, ML Kromrey, S Ichikawa, H Onishi, U Motosugi
Magnetic resonance in medical sciences 19 (1), 64-76, 2020
1422020
Mass‐forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and …
A Muhi, T Ichikawa, U Motosugi, H Sou, K Sano, T Tsukamoto, Z Fatima, ...
Journal of magnetic resonance imaging 35 (4), 827-836, 2012
1402012
Intravoxel incoherent motion imaging of the kidney: alterations in diffusion and perfusion in patients with renal dysfunction
S Ichikawa, U Motosugi, T Ichikawa, K Sano, H Morisaka, T Araki
Magnetic resonance imaging 31 (3), 414-417, 2013
1382013
Additional value of gadoxetic acid‐DTPA‐enhanced hepatobiliary phase MR imaging in the diagnosis of early‐stage hepatocellular carcinoma: comparison with dynamic triple‐phase …
H Haradome, L Grazioli, R Tinti, M Morone, U Motosugi, K Sano, ...
Journal of Magnetic Resonance Imaging 34 (1), 69-78, 2011
1302011
Clinical practice guidelines for hepatocellular carcinoma: the Japan society of hepatology 2021 version (5th JSH‐HCC guidelines)
K Hasegawa, N Takemura, T Yamashita, T Watadani, M Kaibori, S Kubo, ...
Hepatology Research 53 (5), 383-390, 2023
1242023
MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging
T Ichikawa, SM Erturk, H Sou, H Nakajima, T Tsukamoto, U Motosugi, ...
American journal of roentgenology 187 (6), 1513-1520, 2006
1202006
Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis
S Ichikawa, U Motosugi, H Morisaka, K Sano, T Ichikawa, A Tatsumi, ...
Magnetic resonance imaging 33 (1), 26-30, 2015
1152015
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20